Premaitha Health PLC (LSE:NIPT) - Share price - Overview

Stock Report

Premaitha Health PLC NIPT

Last Price
GBX11.50

Day Change
0.38|3.37%

As of 24/02/2017
17:21:48 GMT | GBX
Minimum 15 Minutes Delay.

Last Close11.13p
Day Range10.75 - 11.64
Mkt Cap28.19Mil
52-Wk Range6.50 - 12.40
Yield %0.00
ISINGB00BN31ZD89
Volume2,200,281
P/E-3.56
P/S10.23
P/CF-3.57

Share Price

Total Returns 24/02/2017

 Chg (%)  
More ...
Premaitha Health PLC48.39 
FTSE 100 TR GBP2.45
 
Financials
201420152016
More ...
Income Statement
Turnover-0.122.45
Operating Profit--6.95-12.03
Net Profit--6.87-12.08
Reported EPS--4.61-6.00
Balance Sheet
Current Assets-4.308.56
Non Current Assets-1.351.94
Total Assets-5.6510.49
Current Liabilities-1.597.48
Total Liabilities-1.759.00
Total Equity-3.901.49
Cash Flow
Operating Cash Flow--4.87-7.04
Net Change in Cash-2.452.63
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-5.79-1.55--7.42---
2018-2.36-0.55--20.91---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
12/04/2016PurchaseMr. Adam Reynolds6.50380,00024,700.00
09/03/2016PurchaseMr. Adam Reynolds8.00500,00040,000.00
09/03/2016PurchaseDr. Stephen Little8.00700,00056,000.00

Company Profile

Premaitha Health PLC is a molecular diagnostic company. The Company developed the IONA test, an in vitro diagnostic non-invasive pre-natal screening test for fetal chromosomal abnormalities such as Down's syndrome.

Sector

Diagnostics & Research

Market Position

1272 of 1852 Companies

Index

FTSE AIM All Share

Outlook

(21/12/2016) no outlook statement

Next Event 31/03/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-17.8014.3416.13
Div Yld (E)0.003.764.10
PEG (E)0.00-0.431.08
ROCE-200.13202.62104.73
Op Mrgn-246.53-9.81-16.30
EPS Grwth0.0043.0235.18
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
Chief Executive OfficerDr. Stephen Little
Chief Financial Officer & Company SecretBarry Hextall
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.